Trademark Overview
On Thursday, March 2, 2023, a trademark application was filed for GALSINTO with the United States Patent and Trademark Office. The USPTO has given the GALSINTO trademark a serial number of 97820644. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, March 5, 2024. This trademark is owned by MAIA PHARMACEUTICALS, INC.. The GALSINTO trademark is filed in the Pharmaceutical Products category with the following description:
Gastro-intestinal treatment preparations; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention of gallbladder and pancreas disorders; Pharmaceutical preparations for the treatment and prevention of gallbladder, intestinal tract, and pancreas disorders; Pharmaceutical preparations for the treatment of gastrointestinal disorders; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating hypoglycemia; Pharmaceutical preparations for assisting in the diagnosis of gallbladder and pancreas disorders, stimulating gallbladder contraction, stimulating pancreas secretion, and accelerating the transit of barium through the human body; Pharmaceutical preparations, namely, elixirs for the treatment of gallbladder and pancreas disorders, stimulating gallbladder contraction, stimulating pancreas secretion, and accelerating the transit of barium through the human body